Sanofi welcomes France’s Prime Minister Edouard Philippe to Vitry


Sanofi was honored to host France’s Prime Minister Edouard Philippe at our biologics research, development and production site in Vitry-sur-Seine yesterday. 


Prime Minister Edouard Philippe was welcomed by Sanofi Board Chairman Serge Weinberg, Philippe Luscan, Executive Vice President for Industrial Affairs and President Sanofi in France, Marc Bonnefoi, Head of French R&D Hub, and Guillaume Leroy, Country Chair for France. His visit to Vitry, located on the outskirts of Paris, highlights the Prime Minister’s commitment to and interest in innovation and R&D in the healthcare sector.




This visit was an opportunity for the Sanofi team to emphasize the company’s footprint in France, where we employ over 25,000 people and have invested 1.4 billion euros in our production capacity over the last five years. Furthermore, Sanofi invested 2.4 billion euros in research in 2016, making it the number one private sector investor in France.




The story of the Vitry site is one of a successful industrial conversion, from chemistry to biologics, enabling Sanofi to remain at the forefront of the pharmaceutical industry globally. It is the only end-to-end biotechnology site in France, meaning the site hosts everything from research, development, production and packaging for the biological products it produces. The site supports Sanofi’s global research and development portfolio and is currently engaged in some cutting edge research, for instance around multiple myeloma – a very serious form of bone marrow cancer.


Choose the topics that interest you, like: